MAP (mmHg) RCP (BPU/min)

Treatment

SHRNNa

SHRHNa

SHRNNa

SHRHNa

Phase 1 (saline)

136.4 ± 4.4

142.4 ± 4.5

216.0 ± 17.2

172.6 ± 20.6

Phase 2
(CEC 5µg/ kg)

121.0 ± 3.1

138.3 ± 3.2

201.8 ± 25.1

137.4 ± 12.4

Phase 3
(CEC 10µg /kg)

110.2 ± 2.3*

128.6 ± 6.1*

188.6 ± 20.6

158.6 ± 19.5
Table 2: MAP and RCP (BPU) in SHRNNa and SHRHNa rats in the absence and presence of low and high dose of CEC in renal vasoconstrictor experiment. Data are presented as mean ± SEM * p<0.05 vs. Phase1.
Goto home»